alzhub.org
Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Home › Research › Topics › blood-biomarkers

blood-biomarkers

8 studies tagged blood-biomarkers, dated 2022-11-24 to 2025-05-22. Bibliography: BibTeX (.bib) · RIS (.ris)

Newest in this topic

  1. Blood biomarkers of Alzheimer's disease and 12-year muscle strength trajectories in community-dwelling older adults: a cohort study 2025-05-22
  2. Differences in Alzheimer's disease blood biomarker stability: Implications for the use of tau/amyloid ratios 2025-04-01
  3. Blood biomarkers differentiate AD-related versus non-AD-related cognitive deficits 2025-03-01

Studies

8 studies carry this tag.

Date range

2022 to 2025

Top journals

  • Alzheimer's & dementia : the journal of the Alzheimer's Association 4
  • Alzheimer's research & therapy 1
  • Journal of geriatric psychiatry and neurology 1
  • The lancet. Healthy longevity 1
  • Translational psychiatry 1

Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.

  1. Blood biomarkers of Alzheimer's disease and 12-year muscle strength trajectories in community-dwelling older adults: a cohort study

    ✓ Peer-reviewed alzhub usefulness score 71 out of 100. The lancet. Healthy longevity 2025-05-22 Biomarkers

    In adjusted models, higher concentrations of p-tau181 (β per year 0·93 [95% CI 0·71 to 1·16]; p<0·0001), p-tau217 (β per year 1·31 [1·03 to 1·58]; p<0·0001), neurofilament light chain (β per year 0·76 [0·56 to 0·96]; p<0·0001), and GFAP (β per year 0·37 [0·21 to 0·53]; p<0·0001) were associated with an accelerated decline of chair-stand performance over time.

  2. Differences in Alzheimer's disease blood biomarker stability: Implications for the use of tau/amyloid ratios

    ✓ Peer-reviewed alzhub usefulness score 48 out of 100. Alzheimer's & dementia : the journal of the Alzheimer's Association 2025-04-01 Biomarkers

    Differences in the stability of Aβ42 and p-tau217 may lead to altered p-tau217/Aβ42 ratio results if samples are not handled properly during the pre-analytical testing phase.

  3. Blood biomarkers differentiate AD-related versus non-AD-related cognitive deficits

    ✓ Peer-reviewed alzhub usefulness score 57 out of 100. Alzheimer's & dementia : the journal of the Alzheimer's Association 2025-03-01 Biomarkers

    Blood-based biomarkers may differentiate non-AD-related versus AD-related cognitive deficits.

  4. P-tau217 and other blood biomarkers of dementia: variation with time of day

    ✓ Peer-reviewed alzhub usefulness score 52 out of 100. Translational psychiatry 2024-09-13 Biomarkers

    Plasma biomarkers of dementia, including phosphorylated tau (p-tau217), offer promise as tools for diagnosis, stratification for clinical trials, monitoring disease progression, and assessing the success of interventions in those living with Alzheimer's disease.

  5. Blood biomarkers of Alzheimer's disease in the community: Variation by chronic diseases and inflammatory status

    ✓ Peer-reviewed alzhub usefulness score 48 out of 100. Alzheimer's & dementia : the journal of the Alzheimer's Association 2024-05-08 Biomarkers

    In the community, the concentration of AD blood biomarkers varies in relation to medical conditions and systemic inflammation.

  6. Subjective cognitive complaints and blood biomarkers of neurodegenerative diseases: a longitudinal cohort study

    ✓ Peer-reviewed alzhub usefulness score 72 out of 100. Alzheimer's research & therapy 2023-11-11 Biomarkers

    In community and clinical settings, SCC predict both dementia and depression in the absence of dementia.

  7. Sex differences in blood biomarkers and cognitive performance in individuals with autosomal dominant Alzheimer's disease

    ✓ Peer-reviewed alzhub usefulness score 50 out of 100. Alzheimer's & dementia : the journal of the Alzheimer's Association 2023-06-06 Biomarkers

    Our findings suggest that, among PSEN1 mutation carriers, females had a greater rate of neurodegeneration than males, yet it did not predict cognitive performance.

  8. Blood Biomarkers for the Diagnosis of Neurodegenerative Dementia: A Systematic Review

    ✓ Peer-reviewed alzhub usefulness score 72 out of 100. Journal of geriatric psychiatry and neurology 2022-11-24 Biomarkers

    Encouraging results were found for several biomarkers, alone or in combination.

All topic tags with their study counts